For the last two years, India has been fast-tracking COVID-19 supplies in many countries where the pandemic has affected people badly. Vaccines from India continue to be sent overseas as generic drugs like Favipiravir and Remdisivir are in constant demand. Although there are some export curbs, manufacturers continue to supply vital drugs as the shortage is glaring. It is only humane not to ignore the needs of others.

Lotus International, a part of the wholesale pharmacy in India is happy to regain business across the world markets. India which now supplies nearly more than a quarter of export quality drugs to western countries like the USA is back in action. Our supply chains are once again active with good qualityIvermectin tablets from India.

Unlocking export opportunities for Indian vaccine manufacturers

New markets are being created as restrictions now open up for exports of medicines. The danger of increasing stockpiles and its pricing is also over. It is also good to hear that other COVID-19 related supplies like PPE kits, Sanitizers, and Ventilators from India are finding their place in the international market. It continues to boost the chances of a regrowth of wholesale pharmacy in India for manufacturing several other potent drugs.

Where does Lotus International stand in sending supplies?

As a company that has served the global markets for long, Lotus International continues to be a preferred vendor of generic drugs. The manufacturing capacity is realigned towards meeting demands of collaborators in several ways like:

• Having a robust center for research and development to monitor new trends of generating formulations.
• Employing skilled and knowledgeable scientists and analysts related to making generic drugs for wholesale supplies.
• In-house team to do product development and testing according to international protocols.
• Our experts identify the projects and challenges to offer solutions.
• Patent study and filing case studies for evaluation of making drugs.
• Working towards API processes with advanced equipment.
• Preparing pilot projects for several customers (BA/BE).
• Our batches are regularly sent for submissions.
• Ensuring the stable formulations for international demands.

Due to the above core competencies of manufacturers, vaccines from India are accepted in several countries.

Additional advantages

Meeting demands are done via calculated risks in this business. We are able to compete due to:

• Operational excellence in conducting trials
• Focus on scalability of product range
• Patent focus for customers and he chemistries they require
• Quick turnaround time for meeting timelines
• Delivery on time
• Affordable structure of production
• Advanced infrastructure
• Diverse product portfolio of Covid medicines from India

Many other Indian manufacturers have started to export various medicines after a short export curb. There are several countries which have not yet inoculated the entire population. India is still in a position to send the vaccines and other related medicines. It is very important for the country to stay in the race as a vaccine provider globally. There is a huge gap as other providers lack the same robust supply chain for curbing COVID-19 infections.

Lotus International brings a huge experience and supply chain to save lives. As bans have been lifted on exports, do talk to us for your generic drug requirements.